Skip to main content
NCBI home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1979 Jul;139(1):205–211. doi: 10.1128/jb.139.1.205-211.1979

Three types of mycolic acid from Mycobacterium tuberculosis Brévanne: implications for structure-function relationships in pathogenesis.

R Toubiana, J Berlan, H Sato, M Strain
PMCID: PMC216846  PMID: 110779

Abstract

Saponification of the chloroform-soluble wax from Mycobacterium tuberculosis Brévanne led to the isolation of three classes of mycolic acid containing characteristic functional groups along the methylene backbone: type alpha (two cyclopropane rings); type beta (methoxyl, methyl, and cyclopropane); and type gamma (ketone, methyl, and cyclopropane). The structures of these acids were elucidated principally by mass spectrometry. The high mass region of the keto mycolate is presented showing the meromycolal and molecular ion regions. This is first time a molecular peak for this mycolic acid has been reported. The structure of the keto mycolate was further substantiated by study of the mass spectral fragmentation of its dithioketal derivative. Within each type of acid, a series of homologs was encountered, varying according to the number of methylene units in the backbone chain. Chromatographic and infrared spectrophotometric evidence is presented for the alkali-induced isomerization of the three types of mycolates.

Full text

PDF
205

Images in this article

206Image
on p.206

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam A., Senn M., Vilkas E., Lederer E. Spectrométrie de masse de glycolipides. 2. Diesters de tréhalose naturels et synthétiques. Eur J Biochem. 1967 Nov;2(4):460–468. doi: 10.1111/j.1432-1033.1967.tb00160.x. [DOI] [PubMed] [Google Scholar]
  2. Asselineau C., Montrozier H., Prome J. C. Structure des acides alpha-mycoliques isolés de la souche Canetti de Mycobacterium tuberculosis. Bull Soc Chim Fr. 1969 Feb;2:592–596. [PubMed] [Google Scholar]
  3. Bekierkunst A., Levij I. S., Yarkoni E. Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Guérin. Science. 1971 Dec 17;174(4015):1240–1242. doi: 10.1126/science.174.4015.1240. [DOI] [PubMed] [Google Scholar]
  4. Bekierkunst A., Wang L., Toubiana R., Lederer E. Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression. Infect Immun. 1974 Nov;10(5):1044–1050. doi: 10.1128/iai.10.5.1044-1050.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Etemadi A. H., Lederer E. Sur la structure des acides alpha-mycoliques de la souche humaine test de Mycobacterium tuberculosis. Bull Soc Chim Fr. 1965 Sep;9:2640–2645. [PubMed] [Google Scholar]
  6. FREUND J. The mode of action of immunologic adjuvants. Bibl Tuberc. 1956;(10):130–148. [PubMed] [Google Scholar]
  7. Gensler W. J., Marshall J. P. Structure of mycobacterial bis-cyclopropane mycolates by mass spectrometry. Chem Phys Lipids. 1977 Jun;19(2):128–143. doi: 10.1016/0009-3084(77)90093-7. [DOI] [PubMed] [Google Scholar]
  8. Goren M. B. Mycobacterial lipids: selected topics. Bacteriol Rev. 1972 Mar;36(1):33–64. doi: 10.1128/br.36.1.33-64.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kato M., Tamura T., Silve G., Asselineau J. Chemical structure and biochemical activity of cord factor analogs. A comparative study of esters of methyl glucoside and non-hydroxylated fatty acids. Eur J Biochem. 1978 Jul 3;87(3):497–504. doi: 10.1111/j.1432-1033.1978.tb12400.x. [DOI] [PubMed] [Google Scholar]
  10. Meyer T. J., Ribi E. E., Azuma I., Zbar B. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J Natl Cancer Inst. 1974 Jan;52(1):103–111. doi: 10.1093/jnci/52.1.103. [DOI] [PubMed] [Google Scholar]
  11. Qureshi N., Takayama K., Jordi H. C., Schnoes H. K. Characterization of the purified components of a new homologous series of alpha-mycolic acids from Mycobacterium tuberculosis H37Ra. J Biol Chem. 1978 Aug 10;253(15):5411–5417. [PubMed] [Google Scholar]
  12. Ribi E. E., Meyer T. J., Azuma I., Zbar B. Mycobacterial cell wall components in tumor suppression and regression. Natl Cancer Inst Monogr. 1973 Dec;39:115–119. [PubMed] [Google Scholar]
  13. Steck P. A., Schwartz B. A., Rosendahl M. S., Gray G. R. Mycolic acids. A reinvestigation. J Biol Chem. 1978 Aug 25;253(16):5625–5629. [PubMed] [Google Scholar]
  14. Strain S. M., Toubiana R., Ribi E., Parker R. Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3". Biochem Biophys Res Commun. 1977 Jul 25;77(2):449–456. doi: 10.1016/s0006-291x(77)80001-6. [DOI] [PubMed] [Google Scholar]
  15. Yarkoni E., Rapp H. J., Polonsky J., Lederer E. Immunotherapy with an intralesionally administered synthetic cord factor analogue. Int J Cancer. 1978 Nov 15;22(5):564–569. doi: 10.1002/ijc.2910220510. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES